![Brian Peter Zambrowicz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Peter Zambrowicz
Directeur/Membre du Conseil chez
Texas A&M Institute for Genomic Medicine
Profil
Brian Peter Zambrowicz is the founder of Lexicon Pharmaceuticals, Inc. which was founded in 1995.
He held the title of Chief Scientific Officer & Executive VP from 2011 to 2015.
Currently, he is the Director at Texas A&M Institute for Genomic Medicine.
He previously worked as a Director & Senior Scientific Advisor at Nuevolution AB. Dr. Zambrowicz earned a doctorate degree from the University of Washington and an undergraduate degree from the University of Wisconsin.
Postes actifs de Brian Peter Zambrowicz
| Sociétés | Poste | Début |
|---|---|---|
Texas A&M Institute for Genomic Medicine
 Texas A&M Institute for Genomic Medicine Miscellaneous Commercial ServicesCommercial Services Focuses in research and development for medical industry | Directeur/Membre du Conseil | - |
Anciens postes connus de Brian Peter Zambrowicz
| Sociétés | Poste | Fin |
|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Fondateur | 24/02/2015 |
| NUEVOLUTION AB (PUBL) | Directeur/Membre du Conseil | - |
Formation de Brian Peter Zambrowicz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
47
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Lexicon Pharmaceuticals, Inc.
 Lexicon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuevolution AB
 Nuevolution AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products for treatment of oncology and chronic inflammatory diseases | Health Technology |
Texas A&M Institute for Genomic Medicine
Texas A&M Institute for Genomic Medicine Miscellaneous Commercial ServicesCommercial Services Focuses in research and development for medical industry | Commercial Services |
Choisissez Zonebourse 
